ANDA 213763, held by Ingenus Pharms LLC. Amphetamine Sulfate.
As of Nov 16, 2026, ANDA 213763 (Amphetamine Sulfate), held by Ingenus Pharms LLC, was first approved by FDA on Aug 24, 2020, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 24, 2020 | Original application | Approved | None posted |
| Amphetamine Sulfate5MG · tablet;oral | Amphetamine Sulfate | Discontinued |
| Amphetamine Sulfate10MG · tablet;oral | Amphetamine Sulfate | Discontinued |
| Aug 20, 2025 | Supplement 3Labeling · Standard review | Approved | None posted |
| Oct 13, 2023 | Supplement 2Labeling · Standard review | Approved | None posted |
| Feb 25, 2022 | Supplement 1Labeling · Standard review | Approved | None posted |
| Aug 24, 2020 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters